These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28812923)

  • 1. The use of prophylactic Nunchaku stents to reduce the risk of nasolacrimal duct obstruction in patients with midfacial tumours undergoing radiotherapy.
    Juniat VAR; Rajak S
    Orbit; 2017 Oct; 36(5):298-300. PubMed ID: 28812923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of functional epiphora in patients with an anatomically patent dacryocystorhinostomy.
    Shams PN; Chen PG; Wormald PJ; Sloan B; Wilcsek G; McNab A; Selva D
    JAMA Ophthalmol; 2014 Sep; 132(9):1127-32. PubMed ID: 24903661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nasolacrimal stent for epiphora caused by obstruction of the nasolacrimal duct].
    Posthuma BJ; van Imhoff WL; van Wezer JE
    Ned Tijdschr Geneeskd; 1997 Feb; 141(7):339-41. PubMed ID: 9132609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of nasolacrimal duct obstruction in adults with polyurethane stent.
    Yazici B; Yazici Z; Parlak M
    Am J Ophthalmol; 2001 Jan; 131(1):37-43. PubMed ID: 11162977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of the polyurethane stent without fluoroscopic guidance in the treatment of nasolacrimal duct obstruction.
    Lee JS; Jung G; Oum BS; Lee SH; Roh HJ
    Ophthalmology; 2000 Sep; 107(9):1666-70. PubMed ID: 10964826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The polyurethane nasolacrimal duct stent for lower tear duct obstruction: long-term success rate and complications.
    Schaudig U; Maas R
    Graefes Arch Clin Exp Ophthalmol; 2000 Sep; 238(9):733-7. PubMed ID: 11045340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasolacrimal polyurethane stent placement: preliminary results.
    Perena MF; Castillo J; Medrano J; De Gregorio MA; Loras E; Cristobal JA
    Eur J Ophthalmol; 2001; 11(1):25-30. PubMed ID: 11284481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results and factors affecting patency after removal of nasolacrimal stents.
    Kim JH; Shin JH; Song HY; Kang W; Lim JO; Park SH; Ko GY; Yoon HK; Sung KB
    J Vasc Interv Radiol; 2006 Jul; 17(7):1125-30. PubMed ID: 16868165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of preoperative digital subtraction dacryocystography for nasolacrimal stent].
    Xiao MY; Huang PN; Zhang ZS
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):416-8. PubMed ID: 12206023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nasolacrimal stent implantation: report of a case].
    Lunardelli P; Aoki L; Jervásio AC; Zagui RM; Matayoshi S
    Arq Bras Oftalmol; 2008; 71(1):110-4. PubMed ID: 18408851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of complete obstruction of the nasolacrimal system by temporary placement of nasolacrimal polyurethane stents: preliminary results.
    Paúl L; Pinto I; Vicente JM
    Clin Radiol; 2003 Nov; 58(11):876-82. PubMed ID: 14581012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multi-tool to Reduce Nasolacrimal Stent Complications With the Home-Removable Farson Crawford Tube.
    Haering C; Beck KB; Arnold RW
    J Pediatr Ophthalmol Strabismus; 2016; 53(1):52-4. PubMed ID: 26836004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic-assisted retrieval of retained lacrimal stent material in congenital nasolacrimal duct obstruction without dacryocystorhinostomy.
    Ng DS; Chan E; Tong FM; Chow SK; Ko ST
    Orbit; 2016; 35(2):103-5. PubMed ID: 26838355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic findings after nasolacrimal polyurethane stent implantations.
    Lee JH; Kang MS; Yang JW
    Korean J Ophthalmol; 2005 Dec; 19(4):252-7. PubMed ID: 16491813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis of nasolacrimal duct obstruction after major sinus surgery using a silicone stent.
    Fisher EW; Clarke PM; Cheesman AD
    J Laryngol Otol; 1991 Apr; 105(4):299-300. PubMed ID: 2026946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of complete and partial obstruction of the nasolacrimal system with polyurethane stents: initial experience.
    Pulido-Duque JM; Reyes R; Carreira JM; Vega F; Górriz E; Pardo MD; Perez F; Maynar M
    Cardiovasc Intervent Radiol; 1998; 21(1):41-4. PubMed ID: 9473545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributing factors to prevent prolonged epiphora after maxillectomy.
    Yeo NK; Wang JH; Chung YS; Jang YJ; Lee BJ
    Arch Otolaryngol Head Neck Surg; 2010 Mar; 136(3):229-33. PubMed ID: 20231638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasolacrimal duct obstruction treated nonsurgically with use of plastic stents.
    Song HY; Jin YH; Kim JH; Sung KB; Han YM; Cho NC
    Radiology; 1994 Feb; 190(2):535-9. PubMed ID: 8284412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasolacrimal stents in the management of epiphora: medium-term results of a multicenter prospective study.
    Lanciego C; De Miguel S; Perea M; Cano C; García IR; Dávila J; Ibarburen C; Toledano N; Rodriguez-Merlo R; García LG
    J Vasc Interv Radiol; 2001 Jun; 12(6):701-10. PubMed ID: 11389221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasolacrimal stent with shape memory as an advanced alternative to silicone products.
    Park JY; Lee JB; Shin WB; Kang ML; Shin YC; Son DH; Yi SW; Yoon JK; Kim JY; Ko J; Kim CS; Yoon JS; Sung HJ
    Acta Biomater; 2020 Jan; 101():273-284. PubMed ID: 31707084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.